Thrombosis & Haemostasis, TH,TH Open/X
Dec 3, 2025, 02:33
Cancer Patients․ Bleeding Risk Rises with Anticoagulants + Antiangiogenics ?
Thrombosis and Haemostasis Journal has shared on X:
” Does Anticoagulants with Angiogenesis Inhibitors Increase Bleeding in Cancer ?
In this network meta-analysis, Chen et al. found that adding anticoagulation to high-dose bevacizumab or antiangiogenic TKIs might increase bleeding risk.”
Read more here.
Stay updated with Hemostasis Today.
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’
-
Jun 29, 2026, 13:01Edward Lee Carter: Exploring Anticoagulation Paradox
-
Jun 29, 2026, 12:55Salvatore Massimo Petrina: When is it Truly Safe to Stop Anticoagulation after AF Ablation?